Leukocyte and Platelet Rich Plasma Versus Type A Botulinum Toxin Versus Glucocorticoids for the Treatment of Lateral Epicondylalgia: a Randomized, Multicenter, Double-blind, Therapeutic Trial With Three Parallel Arms

Trial Profile

Leukocyte and Platelet Rich Plasma Versus Type A Botulinum Toxin Versus Glucocorticoids for the Treatment of Lateral Epicondylalgia: a Randomized, Multicenter, Double-blind, Therapeutic Trial With Three Parallel Arms

Discontinued
Phase of Trial: Phase III

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Botulinum toxin A (Primary) ; Glucocorticoids (Primary)
  • Indications Tennis elbow
  • Focus Therapeutic Use
  • Acronyms LET
  • Most Recent Events

    • 16 Jun 2017 Status changed from recruiting to discontinued due to stop production PRB kit.
    • 17 Dec 2015 Planned end date changed from 1 Oct 2018 to 1 Jun 2018, as reported by ClinicalTrials.gov.
    • 17 Dec 2015 Planned primary completion date changed from 1 Oct 2018 to 1 Jun 2018, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top